Skip to main navigation

About
- Team
- Contact
Research & Development
Pipeline
Investors
Careers

Press Releases

Press Releases

Year

November 3, 2021

Revolution Medicines to Report Financial Results for Third Quarter 2021 After Market Close on November 10, 2021

September 30, 2021

Revolution Medicines to Present New Preclinical Data from RAS(ON) Inhibitor Programs at AACR-NCI-EORTC Virtual International Conference on Molecular Targets and Cancer Therapeutics

September 15, 2021

Revolution Medicines to Participate in 3rd Annual RAS-Targeted Drug Development Summit

September 7, 2021

Revolution Medicines to Present at H.C. Wainwright 23rd Annual Global Investment Conference

August 11, 2021

Revolution Medicines Reports Second Quarter Financial Results and Update on Corporate Progress

August 4, 2021

Revolution Medicines to Report Financial Results for Second Quarter 2021 After Market Close on August 11, 2021

June 24, 2021

Revolution Medicines Announces Publication of Scientific Paper Describing Novel Class of Anti-Tumor Compounds Targeting mTORC1

June 10, 2021

Revolution Medicines to Host Science Talk Webcast Highlighting Learnings from Recent Preclinical and Clinical Studies of RAS Inhibitors

June 2, 2021

Revolution Medicines to Participate in Goldman Sachs 42nd Annual Global Healthcare Conference

May 18, 2021

Revolution Medicines to Participate in Cowen 2nd Annual Virtual Oncology Innovation Summit

Pagination

First page
Previous page
Page 1
Page 2
Current page 3
Page 4
Page 5
Page 6
Page 7
Page 8
Page 9
Next page
Last page

Displaying 21 - 30 of 87

Email Alerts

RSS Feeds

Print Page

Contact IR

© 2022 Revolution Medicines, Inc. | 700 Saginaw Drive | Redwood City, CA 94063
CCPA Notice | Privacy Policy

Search Investor Relations